IndraLab

Statements

SEL1L binds NTRK1. 5 / 5
1 | 4
sparser
"With an estimated tumor purity of 75% and a mean depth of 853 reads from this sample, the SEL1L-NTRK1 fusion was interpreted as in-frame and likely pathogenic with 176 reads as noted by the genomic testing laboratory."
33406492
sparser
"Genomic testing results (FoundationOne CDx) revealed a SEL1L-NTRK1 fusion, loss of MEN1 , a low tumor mutational burden, and microsatellite-stable status by next-generation sequencing (NGS)."
33406492
sparser
"Molecular testing showed the presence of an SEL1L-NTRK1 fusion."
33406492
sparser
"This particular SEL1L-NTRK1 fusion event showed breakpoints between NTRK1 (chromosome 1: 156841872–156842158) and SEL1L (chromosome 14: 81996399–81996731)."
33406492
biogrid
No evidence text available
25921289